Value proposition

Prapela is a breakthrough noninvasive stimulation therapy that naturally improves breathing and oxygenation in newborns.

Prapela is a breakthrough noninvasive stimulation therapy that naturally improves breathing and oxygenation in newborns. Based on a field of science called Stochastic Resonance, our precise and gentle stimulation improves breathing rhythm and lung function in newborns. Since 2017, we've received over $8M in awards and grants funding the clinical evaluation of our therapy to improve the treatment of opioid-exposed newborns and preterm infants with apnea of prematurity. Next, we aim to improve the treatment of preterm intermittent hypoxemia and bronchopulmonary dysplasia. For more information, visit prapela.com

medical device, Pediatrics, neonatology, neonatal intensive care, therapy, apnea of prematurity, neonatal abstinence syndrome, intermittenty hypoxemia, hypoxia, neonatal incubators, infant sleep, and respiratory synctial virus